Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
FDA · 19 medicines
CBG-MEB · 8 medicines
AIFA · 4 medicines
SFDA · 3 medicines · Historical list
TFDA · 3 medicines
AEMPS · 2 medicines
PHARMAC · 2 medicines
HALMED · 1 medicine
HSA · 1 medicine
Every register, a page at a time. Strengths and packs are on each medicine’s page.
26 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Apo-Lithium Carbonate | Canada | 150 MG | Capsule | Marketed | Apotex INC |
| PMS-Lithium Carbonate - Cap 150MG | Canada | 150 MG | Capsule | Marketed | Pharmascience INC |
| Apo-Lithium Carbonate | Canada | 300 MG | Capsule | Not marketed | Apotex INC |
| PMS-Lithium Carbonate - Cap 300MG | Canada | 300 MG | Capsule | Not marketed | Pharmascience INC |
| PMS-Lithium Carbonate - Cap 600MG | Canada | 600 MG | Capsule | Not marketed | Pharmascience INC |
| Euro Lithium | Canada | 300 MG | Capsule | Cancelled | Euro-Pharm International Canada INC |
| Euro Lithium | Canada | 150 MG | Capsule | Cancelled | Euro-Pharm International Canada INC |
| Lithane | Canada | 300 MG | Capsule | Marketed | Searchlight Pharma INC |
| Lithane | Canada | 150 MG | Capsule | Marketed | Searchlight Pharma INC |
| Lithmax | Canada | 300 MG | Tablet (Extended-Release) | Marketed | Aa Pharma INC |
| PMS-Lithium Citrate | Canada | 8 MMOL / 5 ML | Syrup | Cancelled | Pharmascience INC |
| Dom-Lithium Carbonate | Canada | 300 MG / CAP | Capsule | Cancelled | Dominion Pharmacal |
| Dom-Lithium Carbonate | Canada | 150 MG / CAP | Capsule | Cancelled | Dominion Pharmacal |
| Dom-Lithium Carbonate | Canada | 600 MG / CAP | Capsule | Cancelled | Dominion Pharmacal |
| Pal-Lithium Carbonate | Canada | 600 MG / CAP | Capsule | Cancelled | Paladin Pharma INC. |
| Pal-Lithium Carbonate | Canada | 150 MG | Capsule | Cancelled | Paladin Pharma INC. |
| Pal-Lithium Carbonate | Canada | 300 MG / CAP | Capsule | Cancelled | Paladin Pharma INC. |
| PHL-Lithium Carbonate | Canada | 600 MG | Capsule | Cancelled | Pharmel INC |
| PHL-Lithium Carbonate | Canada | 150 MG | Capsule | Cancelled | Pharmel INC |
| PHL-Lithium Carbonate | Canada | 300 MG | Capsule | Cancelled | Pharmel INC |
| Carbolith | Canada | 150 MG | Capsule | Marketed | Bausch Health, Canada INC. |
| Carbolith | Canada | 600 MG | Capsule | Marketed | Bausch Health, Canada INC. |
| Carbolith | Canada | 300 MG | Capsule | Not marketed | Bausch Health, Canada INC. |
| Lithizine Cap 150MG | Canada | 150 MG / CAP | Capsule | Cancelled | Labs Maney Paul Labs, Division of 471449 (Ont) Ltee/LTD. |
| Lithizine Cap 300MG | Canada | 300 MG / CAP | Capsule | Cancelled | Labs Maney Paul Labs, Division of 471449 (Ont) Ltee/LTD. |
The same brand on several registers.
The companies holding its medicines, the most first.
Substances it shares a medicine with.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, Anvisa, CBG-MEB, FDA, HALMED, Health Canada, HSA, PHARMAC, SFDA and TFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
